Cargando…

A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI

BACKGROUND: Despite advances in anti-platelet treatments, there still exists an early increase in both ischemic as well as bleeding events following primary PCI in patients with ST-elevation myocardial infarction (STEMI). Platelet inhibition data of different anti-platelet treatments in the acute ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koul, Sasha, Andell, Pontus, Martinsson, Andreas, Gustav Smith, J, Scherstén, Fredrik, Harnek, Jan, Götberg, Matthias, Norström, Eva, Björnsson, Sven, Erlinge, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274705/ https://www.ncbi.nlm.nih.gov/pubmed/25516485 http://dx.doi.org/10.1186/1471-2261-14-189

Ejemplares similares

Delay From First Medical Contact to Primary PCI and All‐Cause Mortality: A Nationwide Study of Patients With ST‐Elevation Myocardial Infarction
por: Koul, Sasha, et al.
Publicado: (2014)

Culprit vessel: impact on short-term and long-term prognosis in patients with ST-elevation myocardial infarction
por: Entezarjou, Artin, et al.
Publicado: (2018)

Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction
por: Andell, Pontus, et al.
Publicado: (2014)

β‐Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study
por: Andell, Pontus, et al.
Publicado: (2015)

Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
por: Attar, Rubina, et al.
Publicado: (2020)

Single-center evaluation of a next generation fully repositionable and retrievable transcatheter aortic valve replacement
por: Berntorp, Karolina, et al.
Publicado: (2019)

Peripheral artery disease and outcomes in patients with acute myocardial infarction
por: Attar, Rubina, et al.
Publicado: (2019)

Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE‐SWEDEHEART Trial
por: Wester, Axel, et al.
Publicado: (2019)

Using proximity extension proteomics assay to identify biomarkers associated with infarct size and ejection fraction after ST-elevation myocardial infarction
por: Mohammad, Moman A., et al.
Publicado: (2020)

Mild hypothermia reduces cardiac post-ischemic reactive hyperemia
por: Olivecrona, Goran K, et al.
Publicado: (2007)

Assessment of increasing intravenous adenosine dose in fractional flow reserve
por: Sparv, David, et al.
Publicado: (2017)

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial
por: Andell, Pontus, et al.
Publicado: (2015)

Coronary artery reperfusion: The ADP receptor P2Y(1) mediates early reactive hyperemia in vivo in pigs
por: Olivecrona, Goran K., et al.
Publicado: (2004)

Apyrase treatment of myocardial infarction according to a clinically applicable protocol fails to reduce myocardial injury in a porcine model
por: van der Pals, Jesper, et al.
Publicado: (2010)

Primary PCI versus pharmacoinvasive strategy for ST elevation myocardial infarction
por: Helal, Ayman M., et al.
Publicado: (2018)

Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors ‐ a VALIDATE‐SWEDEHEART Substudy
por: Bergman, Sofia, et al.
Publicado: (2021)

Erythropoietin Reduces Post-PCI Arrhythmias in Patients With ST-elevation Myocardial Infarction
por: Gholamzadeh, Ali, et al.
Publicado: (2015)

Clinical Outcome of Revascularization Deferral With Instantaneous Wave‐Free Ratio and Fractional Flow Reserve: A 5‐Year Follow‐Up Substudy From the iFR‐SWEDEHEART Trial
por: Berntorp, Karolina, et al.
Publicado: (2023)

The safety of introducing a new generation TAVR device: one departments experience from introducing a second generation repositionable TAVR
por: Bjursten, Henrik, et al.
Publicado: (2017)

Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study
por: Andell, Pontus, et al.
Publicado: (2017)

Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New‐Onset Atrial Fibrillation After Acute Myocardial Infarction
por: Batra, Gorav, et al.
Publicado: (2017)

Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction
por: Nordlund, David, et al.
Publicado: (2016)

Gender Related Survival Differences in ST-Elevation Myocardial Infarction Patients Treated with Primary PCI
por: Kanic, Vojko, et al.
Publicado: (2016)

Intracoronary near-infrared spectroscopy and the risk of future cardiovascular events
por: Karlsson, Sofia, et al.
Publicado: (2019)

Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model
por: van der Pals, Jesper, et al.
Publicado: (2010)

Role of the ECG in initial acute coronary syndrome triage: primary PCI regardless presence of ST elevation or of non-ST elevation
por: IJkema, B. B. L. M., et al.
Publicado: (2014)

The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI
por: Kostic, Jelena, et al.
Publicado: (2015)

Analysis of the Best Timing for Applying Tirofiban in PCI Operation for the Patients with ST Segment Elevation Myocardial Infarction
por: Lei, Zhang, et al.
Publicado: (2015)

Assessment of Transportation by Air for Patients with Acute ST-Elevation Myocardial Infarction from Non-PCI Centers
por: Trifan, Angel Liviu, et al.
Publicado: (2021)

Long-Term Outcomes of COVID-19-Associated ST-Elevation Myocardial Infarction Treated With Primary PCI
por: Choudry, Fizzah A., et al.
Publicado: (2022)

Safety of Bivalirudin Combined with Ticagrelor in the Emergency PCI in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Wang, Zheng-Dong, et al.
Publicado: (2022)

Risk of Stroke in Patients With Atrial Fibrillation Is Associated With Stroke in Siblings: A Nationwide Study
por: Berntsson, John, et al.
Publicado: (2020)

Effect of Ischemic Postconditioning on Infarct Size in Patients With ST‐Elevation Myocardial Infarction Treated by Primary PCI Results of the POSTEMI (POstconditioning in ST‐Elevation Myocardial Infarction) Randomized Trial
por: Limalanathan, Shanmuganathan, et al.
Publicado: (2014)

Veno-arterial extracorporeal membrane oxygenation in addition to primary PCI in patients presenting with ST-elevation myocardial infarction
por: van den Brink, F. S., et al.
Publicado: (2017)

Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock
por: Gjesdal, Grunde, et al.
Publicado: (2018)

Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction
por: Desta, Liyew, et al.
Publicado: (2020)

Achieving timely percutaneous reperfusion for rural ST-elevation myocardial infarction patients by direct transport to an urban PCI-hospital
por: Bennin, Charles-Lwanga K, et al.
Publicado: (2016)

Temporal Pattern of CABG and PCI after Non-ST Elevation Myocardial Infarction Among Elderly Patients from NHDS
por: Siddiqui, Muhammad U, et al.
Publicado: (2020)

Adjunctive Catheter-Directed Thrombolysis during Primary PCI for ST-Segment Elevation Myocardial Infarction with High Thrombus Burden
por: Noma, Satsuki, et al.
Publicado: (2022)

Impact of paramedic education on door-to-balloon times and appropriate use of the primary PCI pathway in ST-elevation myocardial infarction
por: Mahadevan, Kalaivani, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6taetv05b2n9c0etd4s0l8j7sl